» Articles » PMID: 16585312

Transcutaneous Bilirubin Levels in the First 96 Hours in a Normal Newborn Population of > or = 35 Weeks' Gestation

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2006 Apr 6
PMID 16585312
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To obtain transcutaneous bilirubin (TcB) measurements, at 6-hour intervals, in the first 96 hours after birth in a normal newborn population (gestational age: > or =35 weeks).

Methods: We performed 9397 TcB measurements on 3984 healthy newborn infants (gestational age: > or =35 weeks) from 6 to 96 hours of age. All measurements were performed in the well-infant nursery with a Draeger Air-Shields transcutaneous jaundice meter (model JM-103), within 2 hours of the designated time.

Results: There was a distinct pattern to the velocity of the increase in TcB levels over different time periods. TcB levels increased in a linear manner most rapidly in the first 6 to 18 hours and then less rapidly from 18 to 42 hours, followed by a much slower increase until peak levels occurred. Decreasing gestational age was associated significantly with higher TcB levels.

Conclusions: We provide data on neonatal bilirubinemia, based on TcB levels determined in a large, predominately white and breastfed, North American population. Infants who require closer evaluation and observation initially are those whose bilirubin levels are > or =95th percentile, ie, increasing more rapidly than 0.22 mg/dL per hour in the first 24 hours, 0.15 mg/dL per hour between 24 and 48 hours, and 0.06 mg/dL per hour after 48 hours. These data should be useful for detecting aberrant trends, identifying infants who need additional evaluation, and planning appropriate follow-up for jaundiced newborns.

Citing Articles

The use of transcutaneous bilirubin nomograms for the prevention of bilirubin neurotoxicity in the neonates.

Casnocha Lucanova L, Zibolenova J, Matasova Jr K, Matasova K, Zibolen M Front Public Health. 2023; 11:1212667.

PMID: 37538268 PMC: 10395091. DOI: 10.3389/fpubh.2023.1212667.


Transcutaneous bilirubinometry versus total serum bilirubin measurement for newborns.

Okwundu C, Olowoyeye A, Uthman O, Smith J, Wiysonge C, Bhutani V Cochrane Database Syst Rev. 2023; 5:CD012660.

PMID: 37158489 PMC: 10167941. DOI: 10.1002/14651858.CD012660.pub2.


Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes.

Elmassry M, Kim S, Busby B PLoS One. 2021; 16(1):e0244876.

PMID: 33411719 PMC: 7790408. DOI: 10.1371/journal.pone.0244876.


Predictive Models for Neonatal Follow-Up Serum Bilirubin: Model Development and Validation.

Chou J JMIR Med Inform. 2020; 8(10):e21222.

PMID: 33118947 PMC: 7661258. DOI: 10.2196/21222.


Turkish Neonatal Society guideline to the approach, follow-up, and treatment of neonatal jaundice.

Coban A, Kaynak Turkmen M, Gursoy T Turk Pediatri Ars. 2019; 53(Suppl 1):S172-S179.

PMID: 31236030 PMC: 6568284. DOI: 10.5152/TurkPediatriArs.2018.01816.